title: Copper is required for cobalt-induced transcriptional activity of hypoxia-inducible factor-1.
abstract: Cobalt inhibits prolyl hydroxylases, leading to the accumulation of hypoxia-inducible factor-1α (HIF-1α) and a concomitant increase in the transcriptional activity of HIF-1. Therefore, cobalt has been under development as a drug for activating HIF-1 under some disease conditions. However, it has been shown that ischemic conditions resulted in the loss of copper, and the activation of HIF-1 would not occur unless copper was supplemented. The present study was undertaken to test the hypothesis that copper is also required for the cobalt activation of HIF-1 transcriptional activity. Human umbilical vein endothelial cells subjected to treatment with cobalt chloride (CoCl(2)) at concentrations above 25 μM for 2 h resulted in an accumulation of HIF-1α, which was determined by Western blot analysis, and an increase in the expression of vascular endothelial growth factor (VEGF), which was determined by real-time reverse transcription-polymerase chain reaction analysis for mRNA levels and enzyme-linked immunosorbent assay analysis for protein levels. The copper chelator tetraethylenepentamine at 25 μM did not significantly affect the accumulation of HIF-1α but blocked increases in VEGF mRNA and protein levels, an effect that could be reversed by the addition of 25 μM copper sulfate (CuSO(4)). In addition, gene silencing of the copper chaperone for Cu,Zn-superoxide dismutase blocked VEGF expression with little effect on cobalt-induced HIF-1α accumulation. The present study thus demonstrates that copper was required for cobalt-activated transcriptional activity of HIF-1, although copper did not affect cobalt-induced accumulation of HIF-1α in the cells.
authors.affiliation: Regenerative Medicine Research Center, Sichuan University West China Hospital, Keyuan Road 4, Gaopeng Street, Chengdu, Sichuan, PR China 610041.
authors.forename: Liying
authors.initials: L
authors.lastname: Qiu
authors.forename: Xueqin
authors.initials: X
authors.lastname: Ding
authors.forename: Zhen
authors.initials: Z
authors.lastname: Zhang
authors.forename: Y James
authors.initials: YJ
authors.lastname: Kang
mesh_terms: D002478:Cells, Cultured; D003035:Cobalt / Q000378:metabolism* / Q000494:pharmacology*; D003300:Copper / Q000378:metabolism*; D019327:Copper Sulfate / Q000494:pharmacology; D005029:Ethylenediamines / Q000494:pharmacology; D020868:Gene Silencing / Q000187:drug effects; D061307:Human Umbilical Vein Endothelial Cells / Q000187:drug effects / Q000378:metabolism; D006801:Humans; D051795:Hypoxia-Inducible Factor 1, alpha Subunit / Q000235:genetics* / Q000378:metabolism*; D012333:RNA, Messenger / Q000235:genetics; D013482:Superoxide Dismutase / Q000378:metabolism; D014158:Transcription, Genetic / Q000187:drug effects / Q000235:genetics; D015533:Transcriptional Activation / Q000187:drug effects* / Q000235:genetics; D042461:Vascular Endothelial Growth Factor A / Q000235:genetics / Q000378:metabolism
chemical_list: D005029:Ethylenediamines; C497442:HIF1A protein, human; D051795:Hypoxia-Inducible Factor 1, alpha Subunit; D012333:RNA, Messenger; D042461:Vascular Endothelial Growth Factor A; D003035:Cobalt; D003300:Copper; D013482:Superoxide Dismutase; C018021:cobaltous chloride; D019327:Copper Sulfate; C034269:tetraethylenepentamine